Table 2.
Antimicrobial | Acinetobacter baumannii (n = 21) | Klebsiella pneumoniae (n = 5) |
Escherichia coli
(n = 3) |
Stenotrophomonas maltophilia (n = 2) | ||||
---|---|---|---|---|---|---|---|---|
I ∗ | R ∗ | I | R | I | R | I | R | |
Ampicillin | 0 | 100 | 100 | |||||
Piperacillin-tazobactam | 9.5 | 76.2 | 0 | 80.0 | 33.3 | 66.7 | 0 | 100 |
Ceftriaxone | 0 | 100 | 0 | 100 | 0 | 100 | ||
Ceftazidime | 4.8 | 81.0 | 20.0 | 80.0 | 0 | 100 | 0 | 100 |
Cefepime | 19.0 | 76.2 | 20 | 60.0 | 33.3 | 66.7 | ||
Cefoperazone-Sulbactam | 14.3 | 476.2 | 0 | 100 | 33.3 | 66.7 | 0 | 100 |
Aztreonam | 28.6 | 71.4 | 0 | 80.0 | 0 | 66.7 | 0 | 100 |
Imipenem | 23.8 | 66.7 | 25.0 | 75.0 | 0 | 100 | 0 | 100 |
Meropenem | 28.6 | 61.9 | 0 | 100 | 33.3 | 66.7 | 0 | 100 |
Levofloxacin | 33.3 | 57.1 | 20 | 60.0 | 0 | 100 | ||
Minocycline | 28.6 | 52.4 | 20 | 60 | 0 | 66.7 | ||
Gentamycin | 14.3 | 47.6 | 0 | 50 | 0 | 100 | 50 | 50 |
SMZ-TMP | 0 | 47.6 | 0 | 80 | 0 | 50 | ||
TGC∗ | 4.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
∗TGC: tigecycline, I: intermediate, and R: resistance.